Published in J Supramol Struct on January 01, 1977
Synthesis of fibronectin by cultured human endothelial cells. J Exp Med (1978) 2.79
Binding of plasma fibronectin to cell layers of human skin fibroblasts. J Cell Biol (1983) 2.41
Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci U S A (1981) 2.34
Codistribution of pericellular matrix proteins in cultured fibroblasts and loss in transformation: fibronectin and procollagen. Proc Natl Acad Sci U S A (1978) 2.32
Fibronectin synthesis by epithelial crypt cells of rat small intestine. Proc Natl Acad Sci U S A (1978) 1.49
Evidence that fibronectin is the collagen receptor on platelet membranes. Proc Natl Acad Sci U S A (1978) 1.35
Localization of fibronectin within the renal glomerulus and its production by cultured glomerular cells. Am J Pathol (1979) 1.35
Attachment and spreading of baby hamster kidney cells to collagen substrata: effects of cold-insoluble globulin. Proc Natl Acad Sci U S A (1978) 1.28
Deposition of fibronectin in the course of reverse transformation of Chinese hamster ovary cells by cyclic AMP. Proc Natl Acad Sci U S A (1980) 1.06
Rubella: a method for rapid diagnosis of a recent infection by demonstration of the IgM antibodies. Br Med J (1968) 5.54
A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J (1996) 5.33
Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. Biochem J (1979) 4.46
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med (1987) 4.35
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol (1988) 4.34
Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis (1980) 4.10
Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J (1997) 4.07
Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J Cell Biol (1993) 3.96
Distribution of a major connective tissue protein, fibronectin, in normal human tissues. J Exp Med (1978) 3.95
Interaction of soluble fibroblast surface antigen with fribrinogen and fibrin. J Exp Med (1975) 3.91
High molecular weight, cell surface-associated glycoprotein (fibronectin) lost in malignant transformation. Biochim Biophys Acta (1978) 3.89
Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J Cell Biol (1994) 3.68
Binding and factor XIIIa-mediated cross-linking of a 27-kilodalton fragment of fibronectin to Staphylococcus aureus. Science (1980) 3.68
Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor. J Biol Chem (1975) 3.62
Cytopathic effect of rubella virus in RHK21 cells and growth to high titers in suspension culture. Virology (1965) 3.50
Disappearance of a major cell-type specific surface glycoprotein antigen (SF) after transformation of fibroblasts by Rous sarcoma virus. Int J Cancer (1974) 3.24
Fibronectin. Prog Hemost Thromb (1980) 3.23
Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science (1985) 3.17
Interaction of the 70,000-mol-wt amino-terminal fragment of fibronectin with the matrix-assembly receptor of fibroblasts. J Cell Biol (1985) 3.02
Factors influencing the enhancement of the infectivity of poliovirus ribonucleic acid by diethylaminoethyl-dextran. J Virol (1967) 2.95
Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem (1994) 2.87
Distribution of fibroblast surface antigen in the developing chick embryo. J Exp Med (1975) 2.85
Synthesis of fibronectin by cultured human endothelial cells. J Exp Med (1978) 2.79
Induction of a basement membrane glycoprotein in embryonic kidney: possible role of laminin in morphogenesis. Proc Natl Acad Sci U S A (1980) 2.74
Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest (1987) 2.74
Synthesis and secretion of thrombospondin by cultured human endothelial cells. J Cell Biol (1982) 2.72
Growth factors in the extracellular matrix. FASEB J (1997) 2.71
Fibroblast surface antigen: a new serum protein. Biochim Biophys Acta (1973) 2.71
Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A (1996) 2.71
External fibronectin of cultured human fibroblasts is predominantly a matrix protein. J Cell Biol (1978) 2.70
Distribution of fibroblast surface antigen: association with fibrillar structures of normal cells and loss upon viral transformation. J Exp Med (1974) 2.62
Cytovillin, a microvillar Mr 75,000 protein. cDNA sequence, prokaryotic expression, and chromosomal localization. J Biol Chem (1989) 2.61
Fibronectin binding to Staphylococcus aureus. J Biol Chem (1982) 2.54
Hantaviruses: genome structure, expression and evolution. J Gen Virol (1996) 2.47
Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc Natl Acad Sci U S A (1999) 2.47
Fibronectin is produced by human macrophages. J Exp Med (1980) 2.44
Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol (1986) 2.44
Binding of plasma fibronectin to cell layers of human skin fibroblasts. J Cell Biol (1983) 2.41
Novel human serum protein from fibroblast plasma membrane. Nature (1974) 2.35
Rheumatoid factor in acute viral infections: interference with determination of IgM, IgG, and IgA antibodies in an enzyme immunoassay. J Infect Dis (1980) 2.33
Codistribution of pericellular matrix proteins in cultured fibroblasts and loss in transformation: fibronectin and procollagen. Proc Natl Acad Sci U S A (1978) 2.32
Infectious poliovirus RNA: a sensitive method of assay. Virology (1965) 2.28
Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem (1995) 2.28
Appearance and distribution of collagens and laminin in the early mouse embryo. Dev Biol (1980) 2.27
Enhancement of infectivity of poliovirus RNA with diethylaminoethyl-dextran (DEAE-D). Arch Gesamte Virusforsch (1965) 2.25
Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc Natl Acad Sci U S A (1983) 2.23
Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action. Cytokine Growth Factor Rev (1999) 2.22
Structure of the pericellular matrix: association of heparan and chondroitin sulfates with fibronectin-procollagen fibers. Cell (1982) 2.20
Isolation of the pericellular matrix of human fibroblast cultures. J Cell Biol (1979) 2.19
Dimeric character of fibronectin, a major cell surface-associated glycoprotein. Biochem Biophys Res Commun (1977) 2.18
Physiology of fibronectin. Annu Rev Med (1984) 2.17
Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Invest (1980) 2.16
Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol (1994) 2.15
Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J Exp Med (1981) 2.10
Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta (1985) 2.08
Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. J Biol Chem (1987) 2.05
ICAM-2 redistributed by ezrin as a target for killer cells. Nature (1996) 2.04
The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol (1987) 2.04
Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta. Mol Biol Cell (2000) 2.01
Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidylinositol 4, 5-bisphosphate. J Biol Chem (1998) 2.01
Thrombospondin is the endogenous lectin of human platelets. Nature (1982) 1.98
A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J Biol Chem (1998) 1.98
Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J (1987) 1.98
Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J Cell Biol (1988) 1.97
Lysophosphatidic acid and microtubule-destabilizing agents stimulate fibronectin matrix assembly through Rho-dependent actin stress fiber formation and cell contraction. Mol Biol Cell (1997) 1.96
Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol (2001) 1.96
A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J (1996) 1.95
Fibronectin mediates attachment of Staphylococcus aureus to human neutrophils. Blood (1982) 1.93
Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol (1989) 1.93
Epidemiological study of nephropathia epidemica in Finland 1989-96. Scand J Infect Dis (1999) 1.93
Roles of integrins and fibronectin in the entry of Streptococcus pyogenes into cells via protein F1. Mol Microbiol (1998) 1.92
Soluble antigen-antibody complexes and platelet aggregation. Acta Pathol Microbiol Scand (1969) 1.91
Biosynthesis of two subunits of type IV procollagen and of other basement membrane proteins by a human tumor cell line. Eur J Biochem (1980) 1.90
Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci U S A (2001) 1.83
Fibroblast surface antigen produced but not retained by virus-transformed human cells. J Exp Med (1975) 1.81
Chlamydia trachomatis seropositivity during pregnancy is associated with perinatal complications. Clin Infect Dis (1995) 1.79
Rapid diagnosis of hantavirus disease with an IgG-avidity assay. Lancet (1991) 1.79
Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J Cell Biol (1987) 1.79
Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem (1996) 1.79
Fibronectin: structure, assembly, and cardiovascular implications. Arterioscler Thromb Vasc Biol (1998) 1.78
Isolation and characterization of Dobrava hantavirus carried by the striped field mouse (Apodemus agrarius) in Estonia. J Gen Virol (1999) 1.77
Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med (1989) 1.77
Inhibition of binding of fibronectin to matrix assembly sites by anti-integrin (alpha 5 beta 1) antibodies. J Cell Biol (1990) 1.75
Structures of thrombospondins. Cell Mol Life Sci (2008) 1.74
Case-control study on Puumala virus infection: smoking is a risk factor. Epidemiol Infect (2009) 1.74
Microvillus-specific Mr 75,000 plasma membrane protein of human choriocarcinoma cells. J Histochem Cytochem (1987) 1.71
Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation. Mol Cell Biol (1989) 1.70
A common cell-type specific surface antigen in cultured human glial cells and fibroblasts: loss in malignant cells. J Exp Med (1976) 1.70
Latency, activation, and binding proteins of TGF-beta. Microsc Res Tech (2001) 1.70
Cultured human monocytes synthesize and secrete alpha2-macroglobulin. J Exp Med (1977) 1.70
Interactions of thrombospondin with endothelial cells: receptor-mediated binding and degradation. J Cell Biol (1987) 1.68
Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J Biol Chem (1991) 1.68
Transforming growth factors and control of neoplastic cell growth. J Cell Biochem (1987) 1.67
Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. J Biol Chem (1981) 1.66